Hanall Biopharma Co.,Ltd (009420.KS)
KRW 32650.0
(-6.18%)
KRW 32650.0
(-6.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 29.64 Billion | 25.2 Billion | 839.87 Million | 929.29 Million | 20.49 Billion | -2.99 Billion |
| Net Income | 3.5 Billion | 251.47 Million | 8.89 Billion | 19.76 Billion | 19.17 Billion | 3.3 Billion |
| Depreciation & Amortization | 3.24 Billion | 3.05 Billion | 2.72 Billion | 2.89 Billion | 2.71 Billion | 1.98 Billion |
| Deferred income taxes | -2.72 Billion | - | 3.53 Billion | -6.98 Billion | 4.26 Billion | 10.13 Billion |
| Stock-based compensation | 1.62 Billion | 1.87 Billion | 1.61 Billion | 794.3 Million | 507.67 Million | 561.27 Million |
| Change in working capital | 20.18 Billion | 14.85 Billion | -15.24 Billion | -13.4 Billion | -4.06 Billion | -17.15 Billion |
| Other non-cash items | 3.8 Billion | 5.17 Billion | -695.18 Million | -2.12 Billion | -2.11 Billion | -1.83 Billion |
| Investing Cash Flow | -11.88 Billion | -10.59 Billion | 8.02 Billion | -2.31 Billion | -36.59 Billion | -16.1 Billion |
| Investments in PPE | -9.19 Billion | -7.67 Billion | -9 Billion | -7.38 Billion | -8.27 Billion | -1.91 Billion |
| Acquisitions | -1 Billion | 17 Million | -570.54 Million | -4.82 Billion | 9.34 Million | 7.9 Million |
| Investment purchases | -2.67 Billion | -2.93 Billion | 4.39 Billion | -30 Million | -28.33 Billion | -14.62 Billion |
| Sales/Maturities of investments | 999.99 Million | 548.43 Thousand | 17.48 Billion | 5.1 Billion | -9.34 Million | 428.09 Million |
| Other Investing Activities | -10.46 Million | - | -4.27 Billion | 4.82 Billion | 9.34 Million | -290.00 |
| Financing Cash Flow | -813.5 Million | -10.64 Billion | -306.53 Million | -519.34 Million | -459.59 Million | -10.00 |
| Debt repayment | -813.5 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -10 Billion | - | - | - | - |
| Common Stock Issuance | - | 59.86 Million | 408.71 Million | 68.32 Million | - | - |
| Other Financing Activities | -813.5 Million | -698.87 Million | -715.24 Million | -587.67 Million | - | - |
| Accounts receivables | 8.16 Billion | -2.46 Billion | -5.08 Billion | 8.18 Billion | -914.04 Million | 1.43 Billion |
| Accounts payables | 5.51 Billion | 3.36 Billion | -3.18 Billion | 646.62 Million | 1.46 Billion | -2.13 Billion |
| Inventory | -8.29 Billion | -5.81 Billion | -1.47 Billion | -8.43 Billion | 189.78 Million | -1.39 Billion |
| Other working capital | 14.78 Billion | 19.77 Billion | -5.49 Billion | -13.79 Billion | -4.8 Billion | -15.75 Billion |
| Cash at beginning of period | 16.84 Billion | 12.79 Billion | 4.2 Billion | 6.12 Billion | 22.68 Billion | 41.92 Billion |
| Cash at end of period | 33.72 Billion | 16.84 Billion | 12.79 Billion | 4.2 Billion | 6.12 Billion | 22.68 Billion |
| Capital Expenditure | -9.19 Billion | -7.67 Billion | -9 Billion | -7.38 Billion | -8.27 Billion | -1.91 Billion |
| Effect of forex changes on cash | -60.45 Million | 78.63 Million | 30.85 Million | -11.84 Million | 3.19 Million | -135.59 Million |
| Net cash flow / Change in cash | 16.88 Billion | 4.04 Billion | 8.59 Billion | -1.91 Billion | -16.56 Billion | -19.23 Billion |
| Free Cash Flow | 20.44 Billion | 17.52 Billion | -8.16 Billion | -6.46 Billion | 12.21 Billion | -4.91 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.32 Billion | -323.31 Million | -2.86 Billion | 3.5 Billion | 318.81 Million | 7.3 Billion |
| Depreciation & Amortization | 810.06 Million | 795.23 Million | 860.53 Million | 3.24 Billion | 794.62 Million | 796.84 Million |
| Deferred income taxes | - | - | -3.19 Billion | -2.72 Billion | -72.78 Million | 1.24 Billion |
| Stock-based compensation | - | 256.72 Million | 300.7 Million | 1.62 Billion | 306.01 Million | 543.63 Million |
| Change in working capital | -987.15 Million | -5.42 Billion | 4.13 Billion | 20.18 Billion | 20.97 Billion | -13.05 Billion |
| Other non-cash items | 1.28 Billion | 5.91 Billion | 3.76 Billion | 3.8 Billion | -354.41 Million | -131.45 Million |
| Investing Cash Flow | -10.12 Billion | -4.07 Billion | -2 Billion | -11.88 Billion | -4.39 Billion | -2.43 Billion |
| Investments in PPE | -147.51 Million | -4.07 Billion | -2 Billion | -9.19 Billion | -2.99 Billion | -1.76 Billion |
| Acquisitions | - | - | 661.1 Million | -1 Billion | - | - |
| Investment purchases | -2.72 Billion | - | -647.9 Million | -2.67 Billion | 247.9 Million | -661.1 Million |
| Sales/Maturities of investments | - | - | -13.19 Million | 999.99 Million | - | - |
| Other Investing Activities | -9.97 Billion | 1.05 Million | 1.04 Million | -10.46 Million | -1.64 Billion | -12.53 Million |
| Financing Cash Flow | -236.07 Million | -133.66 Million | -246.02 Million | -813.5 Million | -196.06 Million | -185.21 Million |
| Debt repayment | -236.07 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 97.8 Million | - | - | - | - |
| Other Financing Activities | -236.07 Million | - | - | - | - | - |
| Accounts receivables | -522.41 Million | 634.83 Million | -2.52 Billion | 8.16 Billion | -93.42 Million | -1.35 Billion |
| Accounts payables | 58.34 Million | -5.23 Billion | 7.53 Billion | 5.51 Billion | 542.38 Million | -2.23 Billion |
| Inventory | 329.2 Million | 1.01 Billion | -6.18 Billion | -8.29 Billion | -2.05 Billion | 1.43 Billion |
| Other working capital | -793.94 Million | -1.84 Billion | 5.31 Billion | 14.78 Billion | 22.57 Billion | -10.9 Billion |
| Cash at beginning of period | 30.29 Billion | 33.72 Billion | 33.8 Billion | 16.84 Billion | 16.36 Billion | 22.22 Billion |
| Cash at end of period | 17.74 Billion | 30.29 Billion | 33.72 Billion | 33.72 Billion | 33.8 Billion | 16.36 Billion |
| Capital Expenditure | -147.51 Million | -4.07 Billion | -2 Billion | -9.19 Billion | -2.99 Billion | -1.76 Billion |
| Effect of forex changes on cash | 16.06 Million | 5.49 Million | -836.71 Million | -60.45 Million | 55.69 Million | 56.23 Million |
| Net cash flow / Change in cash | -12.55 Billion | -3.42 Billion | -80.36 Million | 16.88 Billion | 17.43 Billion | -5.85 Billion |
| Free Cash Flow | -2.35 Billion | -8.29 Billion | 1 Billion | 20.44 Billion | 18.97 Billion | -5.05 Billion |
002298
RBL
3902
CDTX
JOSTS
JAIBALAJI